PeptidePedia The community reference

Multi-dose vial: difference between revisions

Diff·revision 57 → 58·18:19, 11 Mar 2026

Difference between revision 57 and revision 58 of Multi-dose vial. 2 lines changed; the page grew by 519 bytes.

Revision 57 — 15:43, 3 Mar 2026
UnitsUrsula (talk)
fix significant figures — source gives fewer
24,109 bytes ±0
Revision 58 — 18:19, 11 Mar 2026
FlowTrialFraser (talk)
move table to the section it supports
24,628 bytes +519
134For reconstituted preparations the equivalent record is the reconstitution date, the diluent used and the concentration achieved. None of these is derivable later from the vial: a reconstituted solution offers no visual evidence of its concentration, its diluent or its age. This is the practical reason that the absence of such a record is treated in compounding practice as equivalent to an expired preparation rather than as a documentation lapse.{{r|usp797}}134For reconstituted preparations the equivalent record is the reconstitution date, the diluent used and the concentration achieved. None of these is derivable later from the vial: a reconstituted solution offers no visual evidence of its concentration, its diluent or its age. This is the practical reason that the absence of such a record is treated in compounding practice as equivalent to an expired preparation rather than as a documentation lapse.{{r|usp797}}
135135
+136Two documentation problems specific to unregulated material are worth recording. Lyophilised vials frequently carry no statement of what is in them beyond a compound name and a nominal mass, so the presence or absence of excipients that would affect a reconstituted preparation's pH or preservative effectiveness is unknown. And where a vial is unlabelled entirely — a practice discussed at [[Vial|vial]] — no in-use record can be attached to the container at all, only to the container's surroundings.{{r|ppmdv}}
+137
136== References ==138== References ==
137{{reflist}}139{{reflist}}